Trial
NCT05460871
Pregabalin for Central Sensitization in TKA
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Iowa
Collaborators
—
Condition
Osteo Arthritis Knee
Intervention
Pregabalin 75mg
Why stopped
Enrollment lower than anticipated; none of the subjects completing the study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-04